recombinant platelet factor 4
Term · Oncology and biomedicine · MLC-T-ONC-016454
A recombinant form of the endogenous chemokine platelet factor 4 with potential antiangiogenesis and antineoplastic activities. As a heparin-binding tetramer, recombinant platelet factor 4 inhibits growth factor-stimulated endothelial cell proliferation, migration, and angiogenesis; it has been shown that this agent inhibits fibroblast growth factor 2 (FGF2) angiogenic activity downstream from the FGF2 receptor. Its activity is antagonized by heparin. Recombinant platelet factor 4 may also directly inhibit the proliferation of some tumor cell types.
| Identifier | MLC-T-ONC-016454 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rPF4 |
| Synonyms | platelet factor 4; recombinant human platelet factor 4; CXC-chemokine PF-4; CXCL4 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016454",
"term": "recombinant platelet factor 4",
"field": "Oncology and biomedicine",
"definition": "A recombinant form of the endogenous chemokine platelet factor 4 with potential antiangiogenesis and antineoplastic activities. As a heparin-binding tetramer, recombinant platelet factor 4 inhibits growth factor-stimulated endothelial cell proliferation, migration, and angiogenesis; it has been shown that this agent inhibits fibroblast growth factor 2 (FGF2) angiogenic activity downstream from the FGF2 receptor. Its activity is antagonized by heparin. Recombinant platelet factor 4 may also directly inhibit the proliferation of some tumor cell types.",
"abbreviation": "rPF4",
"synonyms": [
"platelet factor 4",
"recombinant human platelet factor 4",
"CXC-chemokine PF-4",
"CXCL4"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-platelet-factor-4/"
}
Record 14,204 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.